SCHEMBL4040982

SCHEMBL4040982

CCN(CC)c1ccc(Nc2nc(N)n(-c3ccnc(N4CCCCC4)n3)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 11/20 0.46
AXL P30530 11/20 0.46
FLT3 P36888 4/20 0.44
KIT P10721 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4039752 0.92 AXL (0.47) BACE1AXLFLT3KIT
SCHEMBL4046390 0.80 FLT3 (0.67) BACE1AXLFLT3KIT
SCHEMBL4041074 0.79 FLT3 (0.63) BACE1AXLFLT3KIT
SCHEMBL4044785 0.79 AXL (0.53) BACE1AXLFLT3KIT
SCHEMBL4044428 0.77 FLT3 (0.69) AXLFLT3KIT
SCHEMBL4038199 0.77 ULK1 (0.46) BACE1AXLFLT3KIT
SCHEMBL13963820 0.77 AXL (0.33) BACE1AXLFLT3
SCHEMBL4040196 0.75 FLT3 (0.48) BACE1AXLFLT3KIT
SCHEMBL14503017 0.75 NPSR1 (0.61)
SCHEMBL4036203 0.74 AXL (0.52) BACE1AXLFLT3KIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0833886-B1 NONAQUEOUS DETERGENT COMPOSITIONS COMPRISING CLAY SOIL REMOVAL POLYMERS PROCTER & GAMBLE (US) 2000-01-19 EP claimed
US-7902239-B2 Diaminotriazoles useful as inhibitors of protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-03-08 US disclosed
US-7902239-B2 Diaminotriazoles useful as inhibitors of protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-03-08 US disclosed
WO-2009103567-A1 PROCESS FOR THE PREPARATION OF CORROSION RESISTANT ZINC AND ZINC-NICKEL PLATED LINEAR OR COMPLEX SHAPED PARTS ATOTECH DEUTSCHLAND GMBH (DE) 2009-08-27 WO disclosed
EP-1562589-B1 DIAMINOTRIAZOLES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMA (US) 2009-01-07 EP disclosed
US-20080014189-A1 DIAMINOTRIAZOLES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED 2008-01-17 US disclosed
US-20080014189-A1 DIAMINOTRIAZOLES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED 2008-01-17 US disclosed
US-7279469-B2 Diaminotriazoles useful as inhibitors of protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-10-09 US disclosed
US-7279469-B2 Diaminotriazoles useful as inhibitors of protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-10-09 US disclosed
EP-1292724-B1 ZINC-NICKEL ELECTROPLATING TASKEM INC (US) 2005-10-12 EP disclosed
EP-1292724-A4 ZINC-NICKEL ELECTROPLATING TASKEM INC (US) 2004-09-08 EP disclosed
EP-1292724-A1 ZINC-NICKEL ELECTROPLATING Taskem Inc. (US) 2003-03-19 EP disclosed
WO-2001096631-A1 ZINC-NICKEL ELECTROPLATING TASKEM INC. (US) 2001-12-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080014189-A1 DIAMINOTRIAZOLES USEFUL AS INHIBITORS OF PROTEIN KINASES MAP3K20, MAP3K1, MAP3K5 BACE1 3044/4885AXL 762/4885FLT3 220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.